Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
Cash Flows From Operating Activities | |||||
Net Income | 3,598,000 | 10,576,000 | 8,202,000 | 5,654,000 | 2,573,000 |
Depreciation Amortization | 666,000 | 2,777,000 | 1,902,000 | 1,305,000 | 622,000 |
Income taxes - deferred | -27,000 | -1,762,000 | -900,000 | -405,000 | -5,000 |
Accounts receivable | -505,000 | -394,000 | -394,000 | -658,000 | -559,000 |
Other Working Capital | -1,164,000 | 1,248,000 | 377,000 | -987,000 | -324,000 |
Other Operating Activity | 668,000 | 2,577,000 | 1,738,000 | 1,825,000 | 1,530,000 |
Operating Cash Flow | $3,236,000 | $15,022,000 | $10,925,000 | $6,734,000 | $3,837,000 |
Cash Flows From Investing Activities | |||||
PPE Investments | -445,000 | -2,485,000 | -1,490,000 | -831,000 | -232,000 |
Net Acquisitions | -8,000 | -1,388,000 | -1,378,000 | -1,368,000 | -1,368,000 |
Purchase Of Investment | -436,000 | -9,659,000 | -8,475,000 | -566,000 | -52,000 |
Sale Of Investment | 1,363,000 | 7,988,000 | 6,706,000 | 103,000 | 6,000 |
Other Investing Activity | -22,000 | -368,000 | -101,000 | -49,000 | -40,000 |
Investing Cash Flow | $452,000 | $-5,912,000 | $-4,738,000 | $-2,711,000 | $-1,686,000 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | 2,037,000 | 19,626,000 | 20,124,000 | 15,296,000 | 8,117,000 |
Debt Issued | N/A | 5,100,000 | 2,605,000 | 1,000 | N/A |
Debt Repayment | -2,000 | -18,000 | -12,000 | -6,000 | -5,000 |
Common Stock Issued | 256,000 | 1,562,000 | 961,000 | 564,000 | 234,000 |
Common Stock Repurchased | -1,779,000 | -5,607,000 | -2,581,000 | -739,000 | -295,000 |
Dividend Paid | -1,174,000 | -4,670,000 | -3,486,000 | -2,287,000 | -1,085,000 |
Other Financing Activity | -448,000 | -21,691,000 | -21,461,000 | -15,449,000 | -8,051,000 |
Financing Cash Flow | $-1,110,000 | $-5,698,000 | $-3,850,000 | $-2,620,000 | $-1,085,000 |
Exchange Rate Effect | 191,000 | 275,000 | 220,000 | 85,000 | 26,000 |
Beginning Cash Position | 7,770,000 | 4,083,000 | 4,083,000 | 4,083,000 | 4,083,000 |
End Cash Position | 10,539,000 | 7,770,000 | 6,640,000 | 5,571,000 | 5,175,000 |
Net Cash Flow | $2,769,000 | $3,687,000 | $2,557,000 | $1,488,000 | $1,092,000 |
Free Cash Flow | |||||
Operating Cash Flow | 3,236,000 | 15,022,000 | 10,925,000 | 6,734,000 | 3,837,000 |
Capital Expenditure | -479,000 | -2,942,000 | -1,704,000 | -1,045,000 | -446,000 |
Free Cash Flow | 2,757,000 | 12,080,000 | 9,221,000 | 5,689,000 | 3,391,000 |